Freed From Pfizer, Capsugel May Find More Market Opportunities
This article was originally published in The Tan Sheet
Executive Summary
Pfizer's divestiture of Capsugel moves the gelatin capsule manufacturer out from under pharma ownership, potentially opening a door to more business.
You may also be interested in...
Consumer Division Divestments Would Spotlight Firms’ Value – Analysts
Germany’s Merck KGaA could join the ranks of firms like Pfizer potentially looking to leave the consumer health care product business, market analysts argue.
Pfizer CEO Read Expects Gradual Plans For Change In Second Half 2011
Pfizer expects to unveil restructuring plans, including the potential divestiture of its Consumer Healthcare and Nutrition units, in the second half of 2011.
Pfizer Nutrition Continues Launches Despite Divestment Possibility
Pfizer remains active in its international nutritionals business with the launch of an expanded line of pediatric products, even as the company considers divesting the nutrition unit.